Sydney (Australia), January 16 (EFE). Transplantation of fecal microflora may be useful in the treatment of chronic intestinal diseases such as ulcerative colitis, according to a study published today in Australia.
A study by the University of Adelaide included 73 patients with ulcerative colitis, an inflammatory disease that affects the lining of the colon and rectum to which the fecal microflora of the donor was transplanted.
Transplantation of an anaerobic microorganism or its own faeces as a placebo was performed by colonoscopy, followed by two clusters, according to the University of Adelaide.
"The most important difference in this test compared with previous studies is the use of anaerobes (no oxygen) to treat stools," said gastroenterologist Sam Costello, head of this study published in the journal Journal of the American Medical Association,
The expert explained that "many intestinal bacteria die with oxygen exposure, and we know that anaerobic treatment of stools survives a large number of donor bacteria in order to be administered to the patient."
Scientists hope they will continue to develop faecal therapies so that in the future, conventional techniques can be replaced by tablets.